In a previous post, I made reference to drugs coming off prescription-only status, thus becoming subject to Oklahoma sales tax. The drug I had in mind when I wrote that was Xyzal (levocetirizine), which the FDA approved for over-the-counter sales earlier this year, spurring the production of annoying little TV spots like this:
I was cross-checking this with Wikipedia, which is usually at least somewhat reliable on the subject of prescription drugs, and stumbled across this bit of weirdness:
It is sold under the following brand names:
- Xyzal in Australia, Austria, Croatia, Czech Republic, Finland, France, India, Ireland (also Rinozal), Italy, Lithuania, Netherlands, Portugal, Romania, Taiwan, Thailand, Turkey, The Philippines, Serbia, Slovakia, Slovenia, South Africa and UK. On May 25, 2007, the United States Food and Drug Administration approved Xyzal, where it is co-marketed by Sanofi-Aventis.
- Xusal in Germany;
- Xozal in Greece;
- Cezera in Poland;
- Xazal in Spain;
- Xuzal in Mexico.
And half a dozen others that don’t sound like that.
Incidentally, Xyzal is an enantiomer of Zyrtec (cetirizine): the two molecules are mirror images of one another. Saves a bundle on research, I’ll bet.